DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Dr. Lal Path Labs Ltd. — Outcome of Board Meeting

NSE 1 hr ago·4 Nov 2026, 7:59 am

Dr. Lal Path Labs

Dr. Lal Path Labs Ltd. has informed the stock exchanges that its board has approved the financial results for the quarter ended September 30, 2026. This is a routine corporate disclosure required for listed companies to keep investors updated on their performance.

For investors, this update is crucial as it provides the first official data point on the company's financial health following the end of the quarter. It allows shareholders to assess the company's operational efficiency and financial position against market expectations.

Investors should focus on the detailed numbers in the filing, specifically revenue growth and margins. Monitoring the company's commentary on future outlook will also be key to understanding its trajectory in the coming quarters.